Intradiscal therapies are predominantly designed to treat discogenic back pain secondary to internal disc disruption (IDD). Magnetic resonance imaging can be helpful in identifying the proton density of the disc, the presence of radial fissures, and finally, the presence of a posterior annulus high intensity zone (finding highly specific to correlate with IDD). Treatments for discogenic pain are of limited efficacy and range from conservative measures like rehabilitative strategies and polypharmacy to surgery. Surgical interbody fusion of the affected spinal segment as a treatment for IDD is most often indicated in patients when there is extensive disc height loss or structural instability.